$82.5 Million is the total value of Trustees of Columbia University in the City of New York's 17 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
BRKA | BERKSHIRE HATHAWAY INC DELcl a | $30,085,000 | +10.9% | 78 | 0.0% | 36.46% | +0.6% | |
RAPT | RAPT THERAPEUTICS INC | $1,629,000 | +12.4% | 73,383 | 0.0% | 1.97% | +2.0% | |
EVLO | EVELO BIOSCIENCES INC | $1,218,000 | -11.5% | 113,850 | 0.0% | 1.48% | -19.7% | |
KLDO | KALEIDO BIOSCIENCES INC | $1,216,000 | -11.0% | 150,150 | 0.0% | 1.47% | -19.2% | |
MSFT | MICROSOFT CORP | $1,103,000 | +6.1% | 4,678 | 0.0% | 1.34% | -3.8% | |
BRKB | BERKSHIRE HATHAWAY INC DELcl b new | $282,000 | +10.2% | 1,100 | 0.0% | 0.34% | 0.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-17
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
BERKSHIRE HATHAWAY INC DEL | 8 | Q3 2023 | 74.3% |
RAPT THERAPEUTICS INC | 8 | Q3 2023 | 3.7% |
BERKSHIRE HATHAWAY INC DEL | 8 | Q3 2023 | 0.7% |
VOR BIOPHARMA INC | 7 | Q3 2023 | 9.6% |
EVELO BIOSCIENCES INC | 6 | Q1 2023 | 2.3% |
TENAYA THERAPEUTICS INC | 5 | Q3 2023 | 9.2% |
SURROZEN INC | 5 | Q3 2023 | 7.8% |
SURROZEN INC | 5 | Q3 2023 | 0.1% |
SANA BIOTECHNOLOGY INC | 4 | Q3 2023 | 11.4% |
DISC MEDICINE INC | 4 | Q3 2023 | 7.2% |
View Trustees of Columbia University in the City of New York's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-13 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-15 |
13F-HR | 2021-11-15 |
13F-HR | 2021-08-16 |
13F-HR | 2021-05-17 |
13F-HR | 2021-02-16 |
View Trustees of Columbia University in the City of New York's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.